Kevin Liu’s Post

Explore Glioblastoma Clinical Trials! 🧠💡 Looking for insights on glioblastoma research and clinical trials? Our latest article in the WeTrials Learning Centre covers: > Key treatments and emerging therapies > Understanding eligibility and trial phases > How to navigate the clinical trial process > The importance of clinical trials for glioblastoma patients Get informed and empowered! Visit the WeTrials Learning Centre now to read more. Clinical Trials and Glioblastoma: Exploring New Treatment Avenues: https://lnkd.in/gmKVAv7C #ClinicalTrials #GlioblastomaResearch #wetrials #learning #braincancerawareness #supportresearch #glioblastomaawareness Download our App today to register for Brain Tumor Clinical trials: https://linktr.ee/wetrials Glioblastoma Support Network Stupid Cancer Alireza Mansouri Brain Tumour Foundation of Canada Canadian Cancer Society American Cancer Society CURE Childhood Cancer Childhood Cancer Canada Childhood Cancer Society American Brain Tumor Association National Brain Tumor Society Janet (Petruck) Fanaki

Curious about the side effects of Ozempic? 🔍 Here are 5 key points you need to know about the link between Ozempic, Mounjaro & Thyroid Cancer. 🔍Ozempic contains semaglutide, used primarily for diabetes management and weight loss. 🔍The European Medicines Agency has expressed concerns about a possible connection between semaglutide and an increased risk of thyroid cancer. 🔍Ongoing investigations are required to explore this potential link further. 🔍Some studies suggest that GLP-1 receptor agonists like semaglutide may increase thyroid cancer risk, though conclusive evidence is still pending. 🔍It’s essential for patients using Ozempic to be aware of the potential side effects and participate in regular monitoring. Stay informed and proactive about your treatment choices! 🦋 #ThyroidAwareness #DiabetesCare #HealthEducation

Preliminary Clinical Trial Results Show ‘Dramatic and Rapid’ Regression of Glioblastoma after Next Generation CAR-T Therapy via Massachusetts General Hospital: https://lnkd.in/encGTcwR. "A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published today in The New England Journal of Medicine, researchers from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, shared the results for the first three patient cases from a phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma (GBM). The trial, known as INCIPIENT, is designed to evaluate the safety of CARv3-TEAM-E T cells in patients with recurrent GBM. Just days after a single treatment, patients experienced dramatic reductions in their tumors, with one patient achieving near-complete tumor regression. In time, the researchers observed tumor progression in these patients, but given the strategy’s promising preliminary results, the team will pursue strategies to extend the durability of response." #GlioblastomaTreatment #AntiAging #AMMG #AgeManagementMedicine #CMEEducation #ContinuingMedicalEducation #CMEConferences

Preliminary Clinical Trial Results Show ‘Dramatic and Rapid’ Regression of Glioblastoma after Next Generation CAR-T Therapy via Massachusetts General Hospital: https://bit.ly/3SkOmkg. "A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published today in The New England Journal of Medicine, researchers from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, shared the results for the first three patient cases from a phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma (GBM). The trial, known as INCIPIENT, is designed to evaluate the safety of CARv3-TEAM-E T cells in patients with recurrent GBM. Just days after a single treatment, patients experienced dramatic reductions in their tumors, with one patient achieving near-complete tumor regression. In time, the researchers observed tumor progression in these patients, but given the strategy’s promising preliminary results, the team will pursue strategies to extend the durability of response." #GlioblastomaTreatment #AntiAging #AMMG #AgeManagementMedicine #CMEEducation #ContinuingMedicalEducation #CMEConferences

Roberto Pili, MD, associate dean for cancer research and integrative oncology at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, is the principal investigator on a new five-year, $1.8 million grant from the National Cancer Institute (NCI) that focuses on a rare form of kidney cancer found most commonly in children. “We are trying to learn more about the biology of this relatively rare tumor called translocation renal cell carcinoma (tRCC) found primarily in children or young adults. This type of tumor is aggressive, and the standard therapies utilized for the most common types of kidney cancer do not work,” says Pili, who is a professor in the Department of Medicine and chief of the Division of Hematology/Oncology. » Read our story to find out how Pili’s collaborative work with other UB schools is deepening knowledge about tRCC: http://ms.spr.ly/6042mkWiK Medical miracles are years and sometimes decades in the making. When Congress supports The National Institutes of Health with strong, steady funding growth, medical research is strengthened — and critical advances can improve health outcomes. #StartsInAcademicMedicine #UBuffalo #KidneyCancer #TranslocationRenalCellCarcinoma #tRCC #NIH #PediatricKidneyCancer #NCI #Oncology #CancerResearch #FundNIH

Curious about the side effects of Ozempic? 🔍 Here are 5 key points you need to know about the link between Ozempic, Mounjaro & Thyroid Cancer. 🔍Ozempic contains semaglutide, used primarily for diabetes management and weight loss. 🔍The European Medicines Agency has expressed concerns about a possible connection between semaglutide and an increased risk of thyroid cancer. 🔍Ongoing investigations are required to explore this potential link further. 🔍Some studies suggest that GLP-1 receptor agonists like semaglutide may increase thyroid cancer risk, though conclusive evidence is still pending. 🔍It’s essential for patients using Ozempic to be aware of the potential side effects and participate in regular monitoring. Stay informed and proactive about your treatment choices! 🦋 #ThyroidAwareness #DiabetesCare #HealthEducation

TriSalus Life Sciences has unveiled their Pressure Enabled Drug Delivery (PEDD) method designed for precise drug delivery in liver cancer therapy 👏 The study, published in the Journal of Vascular and Interventional Radiology, demonstrates how PEDD, via the TriNav Infusion System, significantly enhances the penetration of glass microspheres in liver tumors. Compared to conventional techniques, this method has shown deeper and more effective delivery into both tumors and surrounding tissues. Such advancements could mean increased therapeutic efficacy and fewer side effects, a win-win for patients and doctors alike which can only be viewed as exciting news! 📈 Dr. Riad Salem, Chief of Interventional Radiology, stresses that PEDD could meet critical unmet needs in liver cancer treatment. CEO Mary Szela highlights the method's promise in targeting tumors without harming healthy tissue. This could transform how we approach liver cancer therapy, making treatment more efficient and targeted ✅ #CancerResearch #MedicalInnovation #OncologyResearch #LiverCancerTreatment #ClinicalResearch #ClinicalTrials #LifeScience #StaffingPartner #ElixirAssociates

The momentum behind hyperthermia treatment for breast cancer continues to build globally. Leading institutions are now conducting groundbreaking research on combined hyperthermia and radiation therapy (HT/RT): > University of Freiburg - Focusing on quality of life improvement through partial remission and potential curative outcomes through complete remission > King's College London - Focusing on quality of life impacts > University of Maryland Medical Center (UMMC) - Leading US advancement of treatment protocols > Cleveland Clinic and the University of California, San Francisco, collaborating with UMMC and leading European Union university hospitals to move advanced treatment options into the U.S. Early results demonstrate significant promise, potentially transforming treatment options for patients with locally recurrent breast cancer. 🔔 Follow HECKEL AMERICA to stay connected with the latest hyperthermic cancer treatment innovation developments. #FutureOfOncology #CancerCare

"Advances in cancer diagnosis and treatment have led to an increase in the number of patients with cancer admitted to the ICU. These developments underscore the transformation of critically ill patients with cancer, once deemed terminal, into a regular facet of intensivists’ caseloads, emphasizing the need for closer collaboration between intensivists and oncologists to formulate evidence-based therapeutic strategies. Thus, intensivists must grasp the nuances of various cancers, their complications, and patient support requirements to deliver tailored, high-quality care." Check out this brilliant piece In Critical Care Science https://lnkd.in/gu-2YyUq

🔬 New research from the IMAGIO Project highlights advanced SPECT imaging techniques to refine liver cancer treatment. 🎯 Researchers are leveraging advance single-photon emission computed tomography (SPECT) imaging techniques to enhance the precision of radioembolization treatments with Angiotensin-2 (AT2). Key Takeaways from the research: 💡Advanced imaging techniques like SPECT enhance accuracy in assessing liver cancer treatments. 💡Image subtraction provides reliable tumour response data, critical for refining treatments. The study gives us more understanding on how advanced imaging techniques can improve how we measure the effects of liver cancer treatments and how imaging techniques can play an important role in cancer treatment while providing doctors with important information for their decision making. 🔗 Learn more: https://lnkd.in/ekhr46V6 #IMAGIO #CancerCare #Innovation #IHI #CancerResearch #Collaboration #LiverCancer #SPECTimaging Cancer Patients Europe - CPE SIOP Europe, the European Society for Paediatric Oncology (SIOPE) Innovative Health Initiative (IHI) COCIR Robert Hofsink Hugo de Jong